錳 Manganese × 微量營養素缺乏
結論：證據支持
錳對「微量營養素缺乏」這個條件存在判讀張力：(1) 在真正可驗證的缺錳情境（罕見的長期 TPN 省略錳、SLC39A8/A14 先天轉運蛋白缺陷）下，口服或腸外補錳確實可以矯正生化與部分臨床表現（PMID 26637979 案例系列、ESPEN PN 指引），屬於機轉合理且有觀察支持的 replacement therapy；(2) 但對絕大多數一般族群，free-living 人類膳食錳缺乏症從未被良好定性確認（L2 PubMed 六項研究一致、NIH ODS 明確聲明、Harvard/Cleveland/AND/AAFP 一致採 food-first），NHANES/EFSA 調查顯示一般飲食錳攝取 2.
C 🟠 C 薄弱證據 已發布 🚨 high — heavy affiliate marketing in TW community
錳對「微量營養素缺乏」這個條件存在判讀張力：(1) 在真正可驗證的缺錳情境（罕見的長期 TPN 省略錳、SLC39A8/A14 先天轉運蛋白缺陷）下，口服或腸外補錳確實可以矯正生化與部分臨床表現（PMID 26637979 案例系列、ESPEN PN 指引），屬於機轉合理且有觀察支持的 replacement therapy；(2) 但對絕大多數一般族群，free-living 人類膳食錳缺乏症從未被良好定性確認（L2 PubMed 六項研究一致、NIH ODS 明確聲明、Harvard/Cleveland/AND/AAFP 一致採 food-first），NHANES/EFSA 調查顯示一般飲食錳攝取 2.1-2.7 mg/day 普遍達 AI。
整體證據級別屬「機轉合理 + 少量人體案例 + 學會 conditional/食物優先」，符合 C 級「薄弱證據」錨點而非 B 級。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.46
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 已發布
信心度
80%
證據方向一致性高
證據層級
E7
單篇小型隨機對照試驗
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.464
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Manganese balance and clinical observations in young men fed a manganese-deficient diet
結論：Experimental manganese depletion produced negative Mn balance, declines in serum Mn, transient dermatitis (miliaria-like rash) in 5 of 7 subjects, increased serum calcium/phosphorus and altered cholesterol; no overt neurologic, hematologic, or growth syndrome emerged within 5 weeks. Authors concluded a clinically recognisable Mn-deficiency syndrome does not occur on customary diets and could only be induced under tightly controlled experimental restriction.
前往 PubMed
International variability in diet and requirements of manganese: Causes and consequences
結論：Authors found no convincing reports of dietary manganese deficiency in free-living humans worldwide; the only contexts in which Mn-status concerns arise clinically are (i) long-term parenteral nutrition where Mn is omitted or biliary clearance is intact, (ii) rare inborn errors (SLC39A8, SLC39A14 mutations) causing functional Mn deficiency with dystonia, and (iii) experimental depletion studies. Recommended against routine Mn supplementation in non-deficient populations and emphasised the manganism (toxicity) signal as the dominant public-health concern.
前往 PubMed
Manganese homeostasis in the nervous system
結論：Reviews intestinal absorption regulation (DMT1, SLC39A8/A14, ferroportin) and confirms that homeostatic mechanisms maintain whole-body Mn even at low intakes; dietary Mn deficiency in humans is essentially theoretical outside of inborn transporter defects (SLC39A8 deficiency presents with hypoglycosylation, intellectual disability, seizures; partially responsive to oral Mn/galactose). The dominant clinical concern remains chronic excess (manganism via inhalation or impaired biliary excretion / TPN).
前往 PubMed
SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation
結論：Loss-of-function SLC39A8 variants cause an inborn intracellular Mn-deficiency syndrome (CDG type IIn) with hypoglycosylation, intellectual disability, seizures, and short stature. High-dose oral manganese supplementation partially restored transferrin glycosylation and improved clinical features in some probands, demonstrating that a *true* Mn-deficiency phenotype is reversible — but the population is vanishingly rare (genetic) and is the only setting in which the literature shows a clinical 'response to Mn repletion'.
前往 PubMed
Trace elements in parenteral nutrition: considerations for the prescribing clinician
結論：Documented case reports of biochemical Mn deficiency in patients receiving Mn-free parenteral nutrition >1-2 years are rare; the much more frequently reported problem is hypermanganesemia with basal-ganglia MRI signal and Parkinsonian features, especially in cholestatic liver disease. ASPEN/ESPEN guidelines and FDA-approved trace-element products have been reformulated to *reduce* Mn content rather than supplement it. Authors conclude routine Mn supplementation outside of demonstrated deficiency is not warranted.
前往 PubMed
L4a US FDA
支持
NUTRIENT SUPPLEMENT 來源↗
L4b EU EFSA
支持
contributes to normal energy-yielding metabolism; contributes to the maintenance of normal bones; contributes to the normal formation of connective tissue; contributes to the protection of cells from oxidative stress 來源↗
L4c UK NHS
謹慎
You should be able to get all the manganese you need from your daily diet. Taking high doses of manganese for long periods of time might cause muscle pain, nerve damage and other symptoms, such as fatigue and depression. For most people, taking 4mg or less of manganese supplements a day is unlikely to cause any harm. For older people, who may be more sensitive to manganese, taking 0.5mg or less… 來源↗
L4d TW TFDA / 衛福部
支持
形態屬膠囊狀、錠狀且標示有每日食用限量之食品，在每日食用量中，其錳之總含量不得高於11 mg。限於補充食品中不足之營養素時使用。 來源↗
L4e WHO
謹慎
A provisional guideline value of 0.08 mg/L for manganese in drinking-water is established based on neurological effects in rats; emerging evidence supports the oral route as a potentially important route of exposure for manganese toxicity. 來源↗
L5a NIH Office of Dietary Supplements
謹慎
Manganese is an essential trace element that is naturally present in many foods and available as a dietary supplement. Manganese is a cofactor for many enzymes, including manganese superoxide dismutase, arginase, and pyruvate carboxylase. Through the action of these enzymes, manganese is involved in amino acid, cholesterol, glucose, and carbohydrate metabolism; reactive oxygen species scavengin… 來源↗
L5b Mayo Clinic
支持
L5c Cleveland Clinic
中性
— 本適應症無對應資料
L5d Harvard Health
中性
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
支持
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽
錳作為單方補充劑針對微量營養素缺乏，在台灣社群（PTT/Dcard/Mobile01/痞客邦）幾乎沒有真實討論。PTT 搜尋結果多為錳乾電池與過錳酸鉀化學/園藝主題；錳僅以綜合維他命或嬰兒奶粉成分表中的微量成分被提及，非單獨補錳經驗。相關內容幾乎全來自商業健康媒體（TVBS、自由健康網、康健、藥局網站）的『補錳防骨鬆消疲勞、多吃堅果蔬果』業配式列舉文，缺乏匿名社群實測辯證。
💬社群實感
無共識（社群幾乎無單方補錳實測討論）
- 多樣且足量的均衡飲食
- 大規模食物強化
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-micronutrient-deficiency-INT-manganese-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "錳能改善微量營養素缺乏",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 2,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟠 C 薄弱證據"
}
}